We announce a new partner channel agreement with Roche Diagnostics for the launch and distribution of the BÜHLMANN fCAL® turbo test. The test – which aids in the diagnosis of inflammatory diseases in the gastrointestinal tract – will be distributed by Roche Diagnostics and used directly on the cobas® c501/c502 chemical analyzer systems in Europe.
The direct application of the BÜHLMANN fCAL turbo® on cobas® c501/c502 analyzers will allow fast and reliable results with little hands-on time. The combination with the BÜHLMANN developed CALEX® Cap extraction device for fast and reliable sample preparation is a significant milestone to break free from cumbersome and laborious manual methods of the past.
Social Links